HIV & Hepatitis Coinfection HIV/HCV Coinfection
HIV/HCV Coinfection
Ribavirin Helps Early Hepatitis C Treatment in People with HIV
- Details
- Category: HIV/HCV Coinfection
- Published on Friday, 11 May 2012 00:00
- Written by Liz Highleyman
Adding ribavirin to pegylated interferon increases the likelihood of a cure for early hepatitis C virus (HCV) infection in people with HIV, according to study findings published in the May 2, 2012, advance online edition of AIDS.
FDA Approves New Fosamprenavir Dose Regimen, Nevirapine Tablets for HIV+ Children
- Details
- Category: HIV Treatment
- Published on Wednesday, 02 May 2012 00:00
- Written by Liz Highleyman
The U.S. Food and Drug Administration (FDA) has approved new dosing recommendations for use of fosamprenavir (Lexiva) oral suspension for children with HIV. The agency also approved a generic nevirapine tablet for use by HIV positive children in PEPFAR countries.
EASL: Boceprevir Improves Cure Rates for HIV/HCV Coinfection but Beware of Drug Interactions
- Details
- Category: HIV/HCV Treatment
- Published on Tuesday, 24 April 2012 00:00
- Written by Liz Highleyman
Adding boceprevir (Victrelis) to pegylated interferon and ribavirin for treatment of chronic hepatitis C in people with HIV substantially increased the likelihood of end-of-treatment response and sustained response 12 weeks after completing therapy, researchers reported at the 47th International Liver Congress (EASL 2012) last week in Barcelona.
Complete Coverage of the 2012 International Liver Congress
- Details
- Category: HBV Treatment
- Published on Wednesday, 25 April 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 2012 International Liver Congress -- 47th Annual Meeting of the European Association for the Study of the Liver (EASL), April 18-22.
Conference highlights include experimental hepatitis C therapies, interferon-free regimens, boceprevir (Victrelis) and telaprevir (Incivek/Incivo) in real-world practice, difficult-to-treat patients, HIV/HCV coinfection, hepatitis B research, and liver cancer research.
HIVandHepatitis.com EASL 2012 conference section
Liver Fibrosis Tests Predict Mortality in HIV/HCV Coinfected Women
- Details
- Category: HIV/HCV Coinfection
- Published on Tuesday, 10 April 2012 00:00
- Written by Liz Highleyman
More advanced liver fibrosis, as diagnosed by 2 non-invasive biomarker tests, is associated with a higher risk of death for HIV positive women coinfected with hepatitis C virus (HCV), according to a report in the March 13, 2012, issue of AIDS.
More Articles...
- CROI: ART Liver Toxicity is Lower with Modern Regimens, but Still a Risk for HIV/HCV Coinfected
- New Guidelines: Antiretroviral Therapy and Optimized Care for People with HIV
- CROI: HIV Treatment May Reduce Mother-to-Child Hepatitis C Transmission
- DHHS Guidelines Recommend ART for All HIV+, New Info on Older Patients and HIV/HCV Coinfection
